You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

1st line chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

Completed
  • FIGO Stage III and IV Ovarian Cancer
  • +2 more
  • ALT-803 Subcutaneous
  • ALT-803 Intraperitoneal
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 5, 2022

Durvalumab in Combination With Standard Chemotherapy of

Recruiting
  • Small-cell Lung Cancer
  • Extensive-stage Small-cell Lung Cancer
    • Néo Fáliro, Greece
      Metropolitan Hospital
    Mar 7, 2023

    Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)

    Active, not recruiting
    • Breast Cancer Metastatic
    • Ravensburg, Germany
      Studienzentrum Onkologie Ravensburg
    Mar 7, 2022

    Nsclc Trial in Lille (procedure, drug, biological)

    Terminated
    • Nsclc
    • Clinical exam
    • +5 more
    • Lille, France
    • +1 more
    Oct 14, 2021

    Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st

    Completed
    • Urologic Neoplasms
      • Kyoto-shi, Japan
        Research Site
      Feb 25, 2021

      Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

      Active, not recruiting
      • Stomach Neoplasms
      • +2 more
      • Beijing, China
      • +10 more
      Dec 21, 2022

      Metastatic Colorectal Cancer Trial in Mecca (Panitumumab)

      Recruiting
      • Metastatic Colorectal Cancer
      • Mecca, Makkah Western, Saudi Arabia
        King Abdullah Medical City, Holy Capital
      Apr 5, 2022

      NSCLC Stage IIIB, NSCLC Stage IV Trial in Frankfurt (Osimertinib, Pemetrexed, Cisplatin)

      Recruiting
      • NSCLC Stage IIIB
      • NSCLC Stage IV
      • Berlin, Germany
      • +8 more
      Oct 25, 2022

      OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

      Recruiting
      • Urothelial Cancer
      • Bristol, United Kingdom
      • +9 more
      Jan 23, 2023

      Acute Myeloid Leukemia, Adult Trial in La Plata, Caba (Evaluation of first line treatment with intensive treatment outcome in

      Recruiting
      • Acute Myeloid Leukemia, Adult
      • Evaluation of first line treatment with intensive treatment outcome in adult patients with AML.
      • La Plata, Buenos Aires, Argentina
      • +1 more
      Nov 9, 2021

      Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial in Montpellier (PIPAC, Cisplatin, Pemetrexed)

      Recruiting
      • Peritoneal Mesothelioma
      • Peritoneal Carcinomatosis
      • PIPAC
      • +2 more
      • Montpellier, France
        Institut réginal du Cancer de Montpellier
      Nov 3, 2021

      1st-line or 2nd-line Chemotherapy for HER2-negative

      Completed
      • Breast Cancer
      • Kobe-city, Hyogo-prefecture, Japan
      • +1 more
      Jun 10, 2021

      Advanced or Metastatic NSCLC Trial in Shanghai (drug, device, combination product)

      Not yet recruiting
      • Advanced or Metastatic NSCLC
      • Shanghai, Shanghai, China
        Lan Mu
      Jun 29, 2021

      Urothelial Carcinoma Trial in Italy (Niraparib, Best supportive care)

      Completed
      • Urothelial Carcinoma
      • Alba, Italy
      • +19 more
      May 16, 2022

      Metastatic Colorectal Cancer Trial in France (FOLFIRI Protocol, Aflibercept Injection)

      Completed
      Has Results
      • Metastatic Colorectal Cancer
      • FOLFIRI Protocol
      • Aflibercept Injection
      • Angers, France
      • +7 more
      May 12, 2021

      Colorectal Cancer Trial in Bobigny (Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen), Chemotherapy ( FOLFIRI

      Completed
      • Colorectal Cancer
      • Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen)
      • Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen) + bevacizumab
      • Bobigny, France
        Hôpital Avicenne
      Oct 30, 2020

      Intrahepatic Cholangiocarcinoma Trial in Worldwide (Cisplatin-gemcitabine, Radiation: SIRT + chemo (cisplatin-gemcitabine))

      Active, not recruiting
      • Intrahepatic Cholangiocarcinoma
      • Spokane, Washington
      • +22 more
      Apr 1, 2022

      Colorectal Cancer Trial in Helsinki (Lactobacillus Rhamnosus supplementation, Placebo administration.)

      Completed
      • Colorectal Cancer
      • Lactobacillus Rhamnosus supplementation
      • Placebo administration.
      • Helsinki, Finland
        Department of Oncology
      Nov 22, 2021

      NSCLC Trial (Aumolertinib, Placebo Aumolertinib)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • (no location specified)
      Jun 10, 2021

      Gastric or Gastroesophageal Junction Adenocarcinoma, AFP Trial in Shenyang (Anti-PD-1 antibody, XELOX)

      Recruiting
      • Gastric or Gastroesophageal Junction Adenocarcinoma
      • AFP
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital & Institute
      Apr 13, 2021

      Pancreatic Cancer, Chemo Effect Trial in Seoul (Gemcitabine, Nab-paclitaxel, Pembrolizumab)

      Recruiting
      • Pancreatic Cancer
      • Chemotherapy Effect
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 15, 2021

      Small Cell Lung Cancer Trial in Shanghai (Irinotecan, Simvastatin)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Shanghai, Shanghai, China
      • +1 more
      Aug 6, 2021

      Small Cell Lung Cancer Trial in Shanghai (Albumin Paclitaxel, Simvastatin)

      Recruiting
      • Small Cell Lung Cancer
      • Shanghai, Shanghai, China
      • +1 more
      Jul 26, 2021

      Colorectal Cancer Trial in Cyprus, United Kingdom (biological, drug, other)

      Completed
      • Colorectal Cancer
      • cetuximab
      • +6 more
      • Nicosia, Cyprus
      • +24 more
      Sep 15, 2021

      Metastatic Colorectal Cancer Trial in Eschweiler, Wilhelmshaven (Maintenance Chemotherapy, Panitumumab (Within maintenance

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Maintenance Chemotherapy
      • +3 more
      • Eschweiler, Germany
      • +1 more
      Sep 9, 2021